Recently, the circulating levels of soluble forms of TLR2, TLR4, and TLR9 were positively associated with advanced stages of gastric cancer, including an upregulation of the protein levels on circulating immune cells in patients with gastric cancer compared to those with premalignant lesions [18]. This evidence concerns the gene TLR9 and gastric cancer.